← Leaderboards
Henry Younghwa Shin
Excitant Therapeutics, Llc
$2,429,498
Attributed
$2,429,498
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $871.2K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,429,498 · 4
By mechanism
R44$1,654,081 · 1
R43$775,417 · 3
Top collaborators
No co-investigators on record.
Most similar at Excitant Therapeutics, Llc
Same institution · by research overlap
- Yuhong Anna Wang$271,325
Others in their field
Other Emerging Leaders on “Small Molecule”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$32,426,535
- Xinhua Li · Nano Terra, Inc.$29,432,783
- Leonard Freedman · Leidos Biomedical Research, Inc.$14,890,784
- Alan Johnson · Hawaii Biotech, Inc.$14,045,226
Research focus
Small MoleculeInflammationVascular Endothelial Growth FactorsAffectInflammatoryExtravasationRetinaToxic EffectNeovascularizationBlood VesselsPharmaceutical PreparationsPpar AlphaAnimal ModelExhibitsAgonistDrug CandidatePathologyLigandsIn VivoBlindnessLeukostasisOralClinical TrialsClinical Research
Grant awards (5)
A Novel Small Molecule for the Prevention and Treatment of Diabetic Retinopathy$782,901
R44 · FY2023 · EY · contact PI
A Novel Small Molecule for the Prevention and Treatment of Diabetic Retinopathy$871,180
R44 · FY2022 · EY · contact PI
A Novel Small Molecule for The Prevention and Treatment of Age-Related Macular Degeneration$277,289
R43 · FY2021 · EY · contact PI
Evaluating therapeutic potential of a novel PPAR-a agonist for wet-AMD$272,889
R43 · FY2020 · EY · contact PI
A novel PPAR-a agonist for treating retinal inflammation and vascular hyper-permeability$225,239
R43 · FY2019 · EY · contact PI